I suspect they fish when conditions permit
Tirzepatide is also a GLP-1 receptor agonist that targets the dual glucose-dependent insulinotropic peptide (GIP)
Appetite scores, rated on a 1 to 10 scale at consistent times of day, reveal whether your GLP-1 and GIP receptor activation is adequate
Data from cardiovascular outcomes trials suggest that GLP-1 agonists provide cardioprotective effects independent of weight loss, including reduced myocardial infarction rates and improved heart failure outcomes
As researchers continue exploring their potential use, including high blood pressure, neurodegenerative diseases like Alzheimers, and even substance use disorders (SUD), it is important for the public to understand their effects and the growing implications of expanding their use
PubMed laboratory research record [PMID: 21701126] PubMed record related to this compound for laboratory literature review